|
業務類別
|
Biotechnology |
|
業務概覽
|
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies. |
| 公司地址
| 245 Main Street, Second Floor, Cambridge, MA, USA, 02142 |
| 電話號碼
| +1 617 500-8080 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.immuneering.com |
| 員工數量
| 53 |
| Ms. Mallory Morales |
Senior Vice President, Finance, Chief Accounting Officer and Treasurer |
-- |
20/04/2026 |
| Dr. Igor Matushansky, M.D.,PhD |
Chief Medical Officer |
-- |
20/04/2026 |
| Mr. Michael D. Bookman |
Chief Legal Officer and Secretary |
美元 502.09K |
20/04/2026 |
| Ms. Leah R. Neufeld |
Chief People Officer |
-- |
20/04/2026 |
| Dr. Benjamin J. Zeskind, PhD |
President, Chief Executive Officer and Director |
美元 641.49K |
20/04/2026 |
| Dr. Brett Hall, PhD |
Chief Scientific Officer |
美元 733.47K |
20/04/2026 |
| Mr. Harold Eugene Brakewood |
Chief Business Officer |
-- |
20/04/2026 |
|
|
| Ms. Laurie B. Keating, J.D. |
Independent Director |
20/04/2026 |
| Mr. Robert J. Carpenter |
Independent Director |
20/04/2026 |
| Dr. Diana F. Hausman, M.D. |
Independent Director |
20/04/2026 |
| Dr. Thomas J. Schall, PhD |
Chairman of the Board |
20/04/2026 |
| Dr. Benjamin J. Zeskind, PhD |
President, Chief Executive Officer and Director |
20/04/2026 |
| Mr. Peter Feinberg |
Independent Director |
20/04/2026 |
|
|
|
|
